• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FAM72 可作为人类肺腺癌预后不良的标志物。

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma.

机构信息

Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, Fujian, China.

出版信息

Aging (Albany NY). 2021 Mar 3;13(6):8155-8176. doi: 10.18632/aging.202625.

DOI:10.18632/aging.202625
PMID:33686947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8034972/
Abstract

FAM72A-D promote the self-renewal of neural progenitor cells. There is accumulating evidence that FAM72 promotes tumorigenicity. However, its effects in lung adenocarcinoma (LUAD) have not been determined. Thus, we evaluated the prognostic value of in LUAD using bioinformatics approaches. In particular, we evaluated the relationship between FAM72 and LUAD using a wide range of databases and analysis tools, including TCGA, GEO, GEPIA, Metascape, cBioPortal, and MethSurv. Compared with its expression in normal lung tissues, FAM72 expression was significantly increased in LUAD tissues. A univariate Cox analysis showed that high FAM72 expression levels were correlated with a poor OS in LUAD. Additionally, FAM72 expression was independently associated with OS through a multivariate Cox analysis. GO and GSEA revealed enrichment in mitotic nuclear division and cell cycle. Moreover, high FAM72 expression was associated with poor survival. An analysis of immune infiltration showed that FAM72 is correlated with immune cell infiltration. Finally, we found that the methylation level was associated with prognosis in patients with LUAD. In summary, these results indicate that FAM72 is a potential molecular marker for poor prognosis in LUAD and provide additional insight for the development of therapies and prognostic markers.

摘要

FAM72A-D 促进神经祖细胞的自我更新。越来越多的证据表明 FAM72 促进了肿瘤的发生。然而,其在肺腺癌(LUAD)中的作用尚未确定。因此,我们使用生物信息学方法评估 FAM72 在 LUAD 中的预后价值。特别是,我们使用了包括 TCGA、GEO、GEPIA、Metascape、cBioPortal 和 MethSurv 在内的广泛数据库和分析工具来评估 FAM72 与 LUAD 之间的关系。与正常肺组织中的表达相比,FAM72 在 LUAD 组织中的表达明显增加。单因素 Cox 分析显示,高 FAM72 表达水平与 LUAD 的不良 OS 相关。此外,多因素 Cox 分析表明,FAM72 表达与 OS 独立相关。GO 和 GSEA 显示有丝分裂核分裂和细胞周期的富集。此外,高 FAM72 表达与不良预后相关。免疫浸润分析表明 FAM72 与免疫细胞浸润相关。最后,我们发现 LUAD 患者的甲基化水平与预后相关。总之,这些结果表明 FAM72 是 LUAD 不良预后的潜在分子标志物,并为治疗和预后标志物的开发提供了额外的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/57551564a746/aging-13-202625-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/38936195bd21/aging-13-202625-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/a390d881ea15/aging-13-202625-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/373e83abf27b/aging-13-202625-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/0038cd88f4fc/aging-13-202625-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/1dab4083dd98/aging-13-202625-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/b15491254e15/aging-13-202625-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/cdec787e4a54/aging-13-202625-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/a46fd9a5b3c3/aging-13-202625-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/57551564a746/aging-13-202625-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/38936195bd21/aging-13-202625-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/a390d881ea15/aging-13-202625-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/373e83abf27b/aging-13-202625-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/0038cd88f4fc/aging-13-202625-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/1dab4083dd98/aging-13-202625-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/b15491254e15/aging-13-202625-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/cdec787e4a54/aging-13-202625-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/a46fd9a5b3c3/aging-13-202625-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb50/8034972/57551564a746/aging-13-202625-g009.jpg

相似文献

1
FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma.FAM72 可作为人类肺腺癌预后不良的标志物。
Aging (Albany NY). 2021 Mar 3;13(6):8155-8176. doi: 10.18632/aging.202625.
2
GREB1L overexpression correlates with prognosis and immune cell infiltration in lung adenocarcinoma.GREB1L 过表达与肺腺癌的预后和免疫细胞浸润相关。
Sci Rep. 2021 Jun 24;11(1):13281. doi: 10.1038/s41598-021-92695-x.
3
Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.SEC61G 在肺腺癌中的预后价值:基于生物信息学和体外验证的综合研究。
BMC Cancer. 2021 Nov 13;21(1):1216. doi: 10.1186/s12885-021-08957-4.
4
Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.蛋白磷酸酶 1 调节亚基 3G(PPP1R3G)与肺腺癌的不良预后和免疫浸润相关。
Bioengineered. 2021 Dec;12(1):8336-8346. doi: 10.1080/21655979.2021.1985817.
5
Family with Sequence Similarity 72 (FAM72) - A prospective biomarker for poor prognosis in patients with oral squamous cell carcinoma.家族性序列相似性 72(FAM72)-口腔鳞状细胞癌患者预后不良的潜在生物标志物。
Arch Oral Biol. 2023 Jul;151:105695. doi: 10.1016/j.archoralbio.2023.105695. Epub 2023 Apr 7.
6
FAM72 family proteins as poor prognostic markers in clear cell renal carcinoma.FAM72家族蛋白作为透明细胞肾细胞癌的不良预后标志物
Biochem Biophys Rep. 2023 Jul 6;35:101506. doi: 10.1016/j.bbrep.2023.101506. eCollection 2023 Sep.
7
Systematic expression analysis of the CELSR family reveals the importance of CELSR3 in human lung adenocarcinoma.系统表达分析 CELSR 家族揭示了 CELSR3 在人肺腺癌中的重要性。
J Cell Mol Med. 2021 May;25(9):4349-4362. doi: 10.1111/jcmm.16497. Epub 2021 Apr 3.
8
The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.PTPRH 的高表达与人类肺腺癌的不良预后相关。
Comput Math Methods Med. 2021 Jul 29;2021:9932088. doi: 10.1155/2021/9932088. eCollection 2021.
9
Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.TTC21A 在肺腺癌中的高表达预示着良好的预后和高水平的免疫浸润。
Int Immunopharmacol. 2020 Jan;78:106077. doi: 10.1016/j.intimp.2019.106077. Epub 2019 Dec 5.
10
GALNT2/14 overexpression correlate with prognosis and methylation: potential therapeutic targets for lung adenocarcinoma.GALNT2/14 过表达与预后和甲基化相关:肺腺癌的潜在治疗靶点。
Gene. 2021 Jul 20;790:145689. doi: 10.1016/j.gene.2021.145689. Epub 2021 May 5.

引用本文的文献

1
Sirtuin family in lung adenocarcinoma.肺癌中的沉默调节蛋白家族。
Discov Oncol. 2025 Jul 23;16(1):1398. doi: 10.1007/s12672-025-03217-4.
2
FAM72A promotes UNG2 degradation and mutagenesis in human cancer cells.FAM72A促进人类癌细胞中UNG2的降解和诱变。
Sci Rep. 2025 Jul 2;15(1):23467. doi: 10.1038/s41598-025-07723-x.
3
Identification of LIMK1 as a biomarker in clear cell renal cell carcinoma: from data mining to validation.鉴定LIMK1作为透明细胞肾细胞癌的生物标志物:从数据挖掘到验证。

本文引用的文献

1
The Roles of Imprinted and Gene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small Cell Lung Cancer Patients.启动子CpG岛低甲基化导致的印记和基因过表达作为非小细胞肺癌患者诊断和预后生物标志物的作用
Cancers (Basel). 2020 Jul 27;12(8):2075. doi: 10.3390/cancers12082075.
2
Misuse of RPKM or TPM normalization when comparing across samples and sequencing protocols.在比较不同样本和测序方案时,滥用 RPKM 或 TPM 标准化。
RNA. 2020 Aug;26(8):903-909. doi: 10.1261/rna.074922.120. Epub 2020 Apr 13.
3
The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation.
J Cancer Res Clin Oncol. 2025 Mar 8;151(3):104. doi: 10.1007/s00432-025-06146-5.
4
B-cell signatures characterize the immune landscape and predict LUAD prognosis via the integration of scRNA-seq and bulk RNA-seq.B细胞特征通过整合单细胞RNA测序和批量RNA测序来表征免疫格局并预测肺腺癌预后。
Sci Rep. 2025 Feb 14;15(1):5453. doi: 10.1038/s41598-025-89213-8.
5
Targeting HNRNPA2B1 to overcome chemotherapy resistance in gastric cancer stem cells: Mechanisms and therapeutic potential.靶向HNRNPA2B1克服胃癌干细胞的化疗耐药性:机制与治疗潜力
J Biol Chem. 2025 Apr;301(4):108234. doi: 10.1016/j.jbc.2025.108234. Epub 2025 Jan 25.
6
A five-gene prognosis model based on lysine β-hydroxybutyrylation site genes to predict the survival and therapy response in pancreatic adenocarcinoma.基于赖氨酸β-羟基丁酰化位点基因的五基因预后模型预测胰腺腺癌的生存和治疗反应
Heliyon. 2024 Jul 8;10(14):e34284. doi: 10.1016/j.heliyon.2024.e34284. eCollection 2024 Jul 30.
7
Prognostic value and molecular mechanisms of OAS1 in lung adenocarcinoma.OAS1 在肺腺癌中的预后价值及分子机制。
BMC Pulm Med. 2024 Sep 27;24(1):473. doi: 10.1186/s12890-024-03206-3.
8
The value analysis of high-resolution thin-layer CT in the identification of early lung adenocarcinoma: An observation study.高分辨率薄层 CT 在早期肺腺癌鉴别诊断中的价值分析:一项观察性研究。
Medicine (Baltimore). 2024 Sep 13;103(37):e39608. doi: 10.1097/MD.0000000000039608.
9
FAM72A degrades UNG2 through the GID/CTLH complex to promote mutagenic repair during antibody maturation.FAM72A 通过 GID/CTLH 复合物降解 UNG2,以促进抗体成熟过程中的诱变修复。
Nat Commun. 2024 Aug 30;15(1):7541. doi: 10.1038/s41467-024-52009-x.
10
The role of tRF-Val-CAC-010 in lung adenocarcinoma: implications for tumorigenesis and metastasis.tRF-Val-CAC-010 在肺腺癌中的作用:对肿瘤发生和转移的影响。
BMC Cancer. 2024 Aug 21;24(1):1033. doi: 10.1186/s12885-024-12800-x.
多发性骨髓瘤的羟甲基组学鉴定 FAM72D 为与增殖相关的 1q21 标志物。
Haematologica. 2020 Mar;105(3):774-783. doi: 10.3324/haematol.2019.222133. Epub 2019 Jun 20.
4
FOX-A1 contributes to acquisition of chemoresistance in human lung adenocarcinoma via transactivation of SOX5.FOX-A1 通过反式激活 SOX5 促进人肺腺癌的化疗耐药性。
EBioMedicine. 2019 Jun;44:150-161. doi: 10.1016/j.ebiom.2019.05.046. Epub 2019 May 27.
5
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.Metascape 为系统水平数据集的分析提供了面向生物学家的资源。
Nat Commun. 2019 Apr 3;10(1):1523. doi: 10.1038/s41467-019-09234-6.
6
Establishing a human adrenocortical carcinoma (ACC)-specific gene mutation signature.建立人肾上腺皮质癌(ACC)特异性基因突变特征。
Cancer Genet. 2019 Jan;230:1-12. doi: 10.1016/j.cancergen.2018.10.005. Epub 2018 Nov 9.
7
A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature.一种癌症组织特异性 FAM72 表达谱定义了一种新的胶质母细胞瘤多形性(GBM)基因突变特征。
J Neurooncol. 2019 Jan;141(1):57-70. doi: 10.1007/s11060-018-03029-3. Epub 2018 Nov 9.
8
CD4 T cell help in cancer immunology and immunotherapy.CD4 T 细胞在癌症免疫和免疫治疗中的作用。
Nat Rev Immunol. 2018 Oct;18(10):635-647. doi: 10.1038/s41577-018-0044-0.
9
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
10
MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data.MethSurv:一个使用 DNA 甲基化数据进行多变量生存分析的网络工具。
Epigenomics. 2018 Mar;10(3):277-288. doi: 10.2217/epi-2017-0118. Epub 2017 Dec 21.